Why is Torrent Pharma falling/rising?

As of 14-Jul, Torrent Pharmaceuticals Ltd. is experiencing a price increase, currently at Rs 3,411.75, reflecting a rise of 104.65 or 3.16%. The stock has shown a positive trend today, gaining after two consecutive days of decline, and it outperformed its sector by 2.26%. Additionally, it has been trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has risen by 2.15%, while it has delivered a 5.24% return over the past month, significantly outperforming the Sensex, which has declined by 1.42% in the same period. The company has also demonstrated strong financial health, with a high return on capital employed (ROCE) of 22.33% and a low debt-to-EBITDA ratio of 1.26 times, contributing to its positive performance.
In the broader market context, Torrent Pharmaceuticals' recent performance contrasts sharply with the Sensex, which has shown a decline over the past week. The stock's consistent returns over the last three years, including a 15.93% return in the past year, highlight its resilience and ability to outperform the broader market. Furthermore, the company has maintained positive results for the last seven consecutive quarters, which bolsters investor confidence. However, it is worth noting that there has been a decline in investor participation, with delivery volume falling by 33.85% against the 5-day average, indicating a potential concern for future trading activity.